Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.

PubWeight™: 1.37‹?› | Rank: Top 10%

🔗 View Article (PMID 27225440)

Published in Malar J on May 26, 2016

Authors

Sócrates Herrera Valencia1,2, Iván Darío Ocampo3,4, María Isabel Arce-Plata3,4, Judith Recht3, Myriam Arévalo-Herrera3,5

Author Affiliations

1: Caucaseco Scientific Research Center/Malaria Vaccine and Drug Development Center, Carrera 37 2B No. 5 E-08, Edificio de profesionales Bambú, Cali, Colombia. sherrera@inmuno.org.
2: Centro Latino Americano de Investigación en Malaria (CLAIM), Cali, Colombia. sherrera@inmuno.org.
3: Caucaseco Scientific Research Center/Malaria Vaccine and Drug Development Center, Carrera 37 2B No. 5 E-08, Edificio de profesionales Bambú, Cali, Colombia.
4: Centro Latino Americano de Investigación en Malaria (CLAIM), Cali, Colombia.
5: Facultad de Salud, Universidad del Valle, Cali, Colombia.

Articles cited by this

Glucose-6-phosphate dehydrogenase deficiency. Lancet (2008) 8.26

G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med (2012) 2.93

Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the "old" and update of the new mutations. Blood Cells Mol Dis (2012) 2.54

Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill? Clin Infect Dis (2012) 2.53

Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia. Proc Natl Acad Sci U S A (1988) 2.33

Diagnosis and management of G6PD deficiency. Am Fam Physician (2005) 2.28

Primaquine to prevent transmission of falciparum malaria. Lancet Infect Dis (2012) 2.00

G6PD deficiency: global distribution, genetic variants and primaquine therapy. Adv Parasitol (2013) 1.85

Glucose-6-phosphate dehydrogenase deficiency and malaria. J Mol Med (Berl) (1998) 1.83

Glucose-6-phosphate dehydrogenase deficiency. Baillieres Best Pract Res Clin Haematol (2000) 1.60

Primaquine: the risks and the benefits. Malar J (2014) 1.51

Mass primaquine treatment to eliminate vivax malaria: lessons from the past. Malar J (2014) 1.27

Plasmodium vivax treatments: what are we looking for? Curr Opin Infect Dis (2011) 1.16

African glucose-6-phosphate dehydrogenase alleles associated with protection from severe malaria in heterozygous females in Tanzania. PLoS Genet (2015) 1.05

Incidence and complete molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Guangxi Zhuang autonomous region of southern China: description of four novel mutations. Haematologica (2006) 1.04

High prevalence of sub-microscopic infections in Colombia. Malar J (2015) 1.04

[Erythrocyte defects and parasitemia density in patients with Plasmodium falciparum malaria in Buenaventura, Colombia]. Rev Panam Salud Publica (2005) 1.03

G6PD deficiency in Latin America: systematic review on prevalence and variants. Mem Inst Oswaldo Cruz (2014) 1.01

Glucose-6-phosphate dehydrogenase deficiency and homozygous sickle cell disease in Congo. Hum Hered (1998) 0.97

Molecular characterization of glucose-6-phosphate dehydrogenase gene defect in the Kuwaiti population. Arch Pathol Lab Med (2005) 0.92

Characterization of glucose-6-phosphate dehydrogenase deficiency and identification of a novel haplotype 487G>A/IVS5-612(G>C) in the Achang population of Southwestern China. Sci China C Life Sci (2007) 0.86

Fatal Primaquine-Induced Hemolysis in a Patient With Plasmodium vivax Malaria and G6PD A(-) Variant in the Brazilian Amazon. Clin Infect Dis (2016) 0.83

Glucose-6-phosphate dehydrogenase deficiency among malaria patients of Honduras: a descriptive study of archival blood samples. Malar J (2015) 0.82

The frequency of glucose-6-phosphate dehydrogenase deficiency in Colombia. Am J Hum Genet (1968) 0.81

Prevalence and molecular characterization of G6PD deficiency in two Plasmodium vivax endemic areas in Venezuela: predominance of the African A-(202A/376G) variant. Malar J (2016) 0.80